SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 200.79-0.2%Nov 14 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DMB who wrote (22810)6/28/1998 11:04:00 PM
From: Hippieslayer  Read Replies (1) of 32384
 
First one that comes to mind is Thalidomide-which I believe is the drug that caused birth defects in pregnant women.

But I must correct myself that the FDA has kept drugs in limbo or prolonged the approval where they might have helped patients where other conventional therapies failed.

In recent, though, the FDA has loosened their noose to allow more patients to get access to experimental drugs.

All you need to do is look to europe or canada which doesn' require as much as the FDA. I don;t know the statistics, but do eupropeans have a higher death rate due to drugs being poorly tested and being approved too quickly than in the US?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News